Literature DB >> 31822564

A 49-residue sequence motif in the C terminus of Nav1.9 regulates trafficking of the channel to the plasma membrane.

Daria V Sizova1,2,3, Jianying Huang1,2,3, Elizabeth J Akin1,2,3, Mark Estacion1,2,3, Carolina Gomis-Perez1,2,3, Stephen G Waxman4,2,3, Sulayman D Dib-Hajj5,2,3.   

Abstract

Genetic and functional studies have confirmed an important role for the voltage-gated sodium channel Nav1.9 in human pain disorders. However, low functional expression of Nav1.9 in heterologous systems (e.g. in human embryonic kidney 293 (HEK293) cells) has hampered studies of its biophysical and pharmacological properties and the development of high-throughput assays for drug development targeting this channel. The mechanistic basis for the low level of Nav1.9 currents in heterologous expression systems is not understood. Here, we implemented a multidisciplinary approach to investigate the mechanisms that govern functional Nav1.9 expression. Recombinant expression of a series of Nav1.9-Nav1.7 C-terminal chimeras in HEK293 cells identified a 49-amino-acid-long motif in the C terminus of the two channels that regulates expression levels of these chimeras. We confirmed the critical role of this motif in the context of a full-length channel chimera, Nav1.9-Ct49aaNav1.7, which displayed significantly increased current density in HEK293 cells while largely retaining the characteristic Nav1.9-gating properties. High-resolution live microscopy indicated that the newly identified C-terminal motif dramatically increases the number of channels on the plasma membrane of HEK293 cells. Molecular modeling results suggested that this motif is exposed on the cytoplasmic face of the folded C terminus, where it might interact with other channel partners. These findings reveal that a 49-residue-long motif in Nav1.9 regulates channel trafficking to the plasma membrane.

Entities:  

Keywords:  Nav1.9; channel trafficking; electrophysiology; functional expression; live imaging; nociception; pain; sensory neurons; sodium channel; structural model; trafficking; voltage clamp

Mesh:

Substances:

Year:  2019        PMID: 31822564      PMCID: PMC6983848          DOI: 10.1074/jbc.RA119.011424

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  The C-terminal region as a modulator of rNa(v)1.7 and rNa(v)1.8 expression levels.

Authors:  Kausalia Vijayaragavan; Said Acharfi; Mohamed Chahine
Journal:  FEBS Lett       Date:  2004-02-13       Impact factor: 4.124

2.  A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons.

Authors:  T R Cummins; S D Dib-Hajj; J A Black; A N Akopian; J N Wood; S G Waxman
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Multiplexed transposon-mediated stable gene transfer in human cells.

Authors:  Kristopher M Kahlig; Sai K Saridey; Aparna Kaja; Melissa A Daniels; Alfred L George; Matthew H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-06       Impact factor: 11.205

4.  Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins.

Authors:  Huaizong Shen; Dongliang Liu; Kun Wu; Jianlin Lei; Nieng Yan
Journal:  Science       Date:  2019-02-14       Impact factor: 47.728

5.  Human embryonic kidney (HEK293) cells express endogenous voltage-gated sodium currents and Na v 1.7 sodium channels.

Authors:  Bingjun He; David M Soderlund
Journal:  Neurosci Lett       Date:  2009-12-17       Impact factor: 3.046

6.  A de novo gain-of-function mutation in SCN11A causes loss of pain perception.

Authors:  Enrico Leipold; Lutz Liebmann; G Christoph Korenke; Theresa Heinrich; Sebastian Giesselmann; Jonathan Baets; Matthias Ebbinghaus; R Oliver Goral; Tommy Stödberg; J Christopher Hennings; Markus Bergmann; Janine Altmüller; Holger Thiele; Andrea Wetzel; Peter Nürnberg; Vincent Timmerman; Peter De Jonghe; Robert Blum; Hans-Georg Schaible; Joachim Weis; Stefan H Heinemann; Christian A Hübner; Ingo Kurth
Journal:  Nat Genet       Date:  2013-09-15       Impact factor: 38.330

7.  Preferential targeting of Nav1.6 voltage-gated Na+ Channels to the axon initial segment during development.

Authors:  Elizabeth J Akin; Laura Solé; Sulayman D Dib-Hajj; Stephen G Waxman; Michael M Tamkun
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

8.  Biophysical and Pharmacological Characterization of Nav1.9 Voltage Dependent Sodium Channels Stably Expressed in HEK-293 Cells.

Authors:  Zhixin Lin; Sonia Santos; Karen Padilla; David Printzenhoff; Neil A Castle
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

9.  Nonmuscle myosin II isoforms interact with sodium channel alpha subunits.

Authors:  Bhagirathi Dash; Chongyang Han; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Mol Pain       Date:  2018-06-29       Impact factor: 3.395

10.  Occurrence, function and evolutionary origins of '2A-like' sequences in virus genomes.

Authors:  Garry A Luke; Pablo de Felipe; Alexander Lukashev; Susanna E Kallioinen; Elizabeth A Bruno; Martin D Ryan
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

View more
  4 in total

Review 1.  Status of peripheral sodium channel blockers for non-addictive pain treatment.

Authors:  Matthew Alsaloum; Grant P Higerd; Philip R Effraim; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2020-10-27       Impact factor: 42.937

Review 2.  iPSCs and DRGs: stepping stones to new pain therapies.

Authors:  Matthew Alsaloum; Stephen G Waxman
Journal:  Trends Mol Med       Date:  2021-12-18       Impact factor: 11.951

3.  Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome.

Authors:  Andoni Echaniz-Laguna; Valérie Biancalana; Aleksandra Nadaj-Pakleza; Emmanuel Fournier; Emma Matthews; Michael G Hanna; Roope Männikkö
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-06-02       Impact factor: 10.154

4.  Characterization of Synthetic Tf2 as a NaV1.3 Selective Pharmacological Probe.

Authors:  Mathilde R Israel; Thomas S Dash; Stefanie N Bothe; Samuel D Robinson; Jennifer R Deuis; David J Craik; Angelika Lampert; Irina Vetter; Thomas Durek
Journal:  Biomedicines       Date:  2020-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.